PwC has launched new offerings aimed at advancing innovation in healthcare.
Here are five things to know about the new offerings.
1. PwC has launched DoubleJump Health, a consumer health accelerator that officials said "speeds the pace of innovation in person-centered health and brings medical and scientific breakthroughs to the market more quickly."
2. There are two solutions PwC is launching first: DoubleJump Interchange, which is designed to get rid of barriers for ecosystem collaboration, data integration and analysis; and Bodylogical from DoubleJump Health, which officials said will help predict chronic health outcomes at an individual and population level.
3. Through the DoubleJump Interchange platform, traditional and non-traditional healthcare stakeholders will be able to connect into a cloud-based interchange to share data, information, research and best practices enterprisewide or between organizations, according to a news release. For instance, the release notes, DoubleJump Interchange can help "connect the dots" between a patient's wearable device data collected at home, to their vital signs taken at a retail clinic, to their historical health data stored with their primary care physician.
4. Bodylogical from DoubleJump Health is a scientifically developed digital model of the human body that allows for true-life simulations to predict the likely progression of chronic diseases in the future based on current actions and interventions, officials said.
They added, "By using Bodylogical, pharmaceutical companies, providers, payers, employers, researchers and consumers can better understand how interventions impact individual patients or patient populations in order to become healthier faster and less expensively."
5. More information about DoubleJump Health, the DoubleJump Interchange and Bodylogical will be available at the HIMSS 2016 Conference & Exhibition in Las Vegas.